James Patrick Kelly, EVP & Chief Financial Officer at Vanda Pharmaceuticals Inc. (VNDA), sold 37,714 shares at $10.19 ($391K) on 2020-03-02, disclosed to the SEC on 2020-03-04.
Seasonal sale ($391k) by EVP & Chief Financial Officer — this insider has traded VNDA in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.19 | 12,968 | $132K | 33.8% |
| 2 | $10.19 | 12,968 | $132K | 33.8% |
| 3 | $10.76 | 5,889 | $63K | 16.2% |
| 4 | $10.76 | 5,889 | $63K | 16.2% |
| Total | $10.37 avg | 37,714 | $391K | 100% |
| Filing → |
| VNDA | SELL | 2019-01-04 | $232K | — | Filing → |
| CBT | SELL | 2018-06-08 | $160K | — | Filing → |
| VNDA | SELL | 2018-03-02 | $319K | — | Filing → |